Clinical Trials Sponsored by EMIS PLC

Total 11505 results

Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

Depressive Disorder, Major

United States
West-Ward Pharmaceutical
Premier Research Group plc

Completed

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

Pain, Postoperative

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Assessment of Effect of Rapastinel on Driving Performance

Driving Performance

United States, Canada
Paion UK Ltd.
Premier Research Group plc

Completed

Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy

Sedation

United States
Wex Pharmaceuticals Inc.
Premier Research Group plc

Terminated

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment (TTX-CINP-201)

Pain | Neuropathic Pain | Peripheral Neuropathy

United States
FrieslandCampina WAMCO Nigeria PLC
Lagos State University

Unknown

The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers (GaGA)

Enterobacteriaceae Infections | Nutritional Deficiency | Iron-deficiency Anemia | Nutritional Stunting | Nutritional Wasting | Malnutrition; Mild
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NRX-1074)

Major Depressive Disorder

United States
CellMed AG, a subsidiary of BTG plc.

Completed

First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100

Healthy

Germany
Emil Loldrup Fosbol
Hvidovre University Hospital; Bispebjerg Hospital; Amager Hospital; Herlev and... and other collaborators

Recruiting

Antibiotics vs Antibiotics and Surgical ThERapy for Infective Endocarditis (ASTERIx)

Endocarditis Infective

Denmark, Netherlands, Sweden
Resverlogix Corp
PPD; ICON plc; Medidata Solutions

Completed

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Depressive Disorder, Major

United States
Paion UK Ltd.
Premier Research Group plc

Completed

A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy

Bronchoscopy

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

Open Label Extension for GLYX13-C-202, NCT01684163

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Withdrawn

Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)

Depressive Disorder, Major
Liquidia Technologies, Inc.
Premier Research Group plc

Completed

Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations

Acute Pain

Denmark
Naurex, Inc, an affiliate of Allergan plc

Completed

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

Healthy

United States
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)

Healthy

Egypt
CellMed AG, a subsidiary of BTG plc.

Terminated

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Intracerebral Hemorrhage (ICH)

Germany
Naurex, Inc, an affiliate of Allergan plc

Completed

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Major Depressive Disorder

United States
CellMed AG, a subsidiary of BTG plc.

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Healthy

Germany
Pharmtechnology LLC
Ligand Research, LLC

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Padagis LLC
Impax Laboratories, LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Atrophy

United States
Saptalis Pharmaceuticals LLC
bioRASI, LLC

Completed

A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

Scabies

United States
Nearmedic Plus LLC
OCT LLC

Terminated

Phase 2a Study of PBTZ169

Tuberculosis
Pure Purr LLC
Pharmaxi LLC

Completed

Study of the Effect of the VR Technology on Recovery of the Autonomic Nervous System in Volunteers Affected by Stress

Stress

Ukraine
Monsanto Company, LLC
Solae, LLC

Completed

Efficacy Study of Stearidonic Acid (SDA) Soybean Oil-containing Foods on Red Blood Cell Fatty Acid Content

Healthy Volunteers | Markers of Cardiovascular Risk

United States
Intensity Therapeutics, Inc.
Premier Research Group plc

Not yet recruiting

A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) (INVINCIBLE-3)

Sarcoma,Soft Tissue
HEM Pharma Inc.
Premier Research Group plc

Not yet recruiting

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

LARS - Low Anterior Resection Syndrome
Tonix Pharmaceuticals, Inc.
Premier Research Group plc

Terminated

Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD (HONOR)

PTSD

United States
Guardant Health, Inc.
Premier Research Group plc

Active, not recruiting

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)

Colorectal Cancer

United States
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ)

Alzheimer Disease

United States, Australia, Canada
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
University of Edinburgh
NHS Lothian; Optos, PLC

Completed

REtinaL Imaging & Ambulatory BLood PrEssure (RELIABLE)

Hypertension | Blood Pressure

United Kingdom
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Paion UK Ltd.
Premier Research Group plc

Completed

A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients

Colonoscopy

United States
Paion UK Ltd.
Premier Research Group plc

Completed

Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy

Colonoscopy

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Slovakia, Poland, Hungary, Japan, Russian Federation
Tonix Pharmaceuticals, Inc.
Premier Research Group plc

Terminated

12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients

PTSD

United States
Rex Bionics Plc
Generic Devices Consulting, Inc.

Completed

Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX (RAPPER II)

Spinal Cord Injury

Australia, United Kingdom, New Zealand
Naurex, Inc, an affiliate of Allergan plc

Completed

Assessment of Abuse Potential of Rapastinel in Humans

Human Abuse Potential

United States
Paion UK Ltd.
Premier Research Group plc

Completed

Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy

Endoscopy | Procedural Sedation

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers

Healthy

United States
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

Healthy

Egypt

Clinical Trials Sponsored by EMIS PLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations